Kevin Brandt - Xtant Medical Senior Vice President Chief Commercial Officer

All Insiders . USA . 
Stock . Xtant Medical Holdings . Stakeholders . Insider . Kevin Brandt
XTNT Stock  USD 0.40  0.01  2.44%   

President

Mr. Kevin D. Brandt is Senior Vice President, Chief Commercial Officer of the Company since 2018.
Age 58
Tenure 6 years
Address 664 Cruiser Lane, Belgrade, MT, United States, 59714
Phone406 388 0480
Webhttps://www.xtantmedical.com
Brandt brings to the Company more than 28 years of experience in the medical device industry. As the former Executive Vice President and Chief Commercial Officer of RTI Surgical, Inc.’s domestic direct business, Mr. Brandt led all domestic direct lines of business for a global surgical implant company marketing biologic, medical and synthetic implants. Prior to joining RTI Surgical in 2012, Mr. Brandt was the president of Osteokinetics, a distributor of Stryker Corporationrationrationration, from 20022012, and from 20002001 he was a senior director for U.S. spine sales at Stryker.

Xtant Medical Management Efficiency

The company has return on total asset (ROA) of (0.1058) % which means that it has lost $0.1058 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.0877) %, meaning that it created substantial loss on money invested by shareholders. Xtant Medical's management efficiency ratios could be used to measure how well Xtant Medical manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Xtant Medical's Return On Tangible Assets are comparatively stable compared to the past year. Return On Assets is likely to gain to 0.01 in 2024, whereas Return On Capital Employed is likely to drop (0.15) in 2024. Change To Liabilities is likely to gain to about 1.9 M in 2024, whereas Total Current Liabilities is likely to drop slightly above 16 M in 2024.
Xtant Medical Holdings currently holds 23.56 M in liabilities with Debt to Equity (D/E) ratio of 0.6, which is about average as compared to similar companies. Xtant Medical Holdings has a current ratio of 3.5, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Xtant Medical's use of debt, we should always consider it together with its cash and equity.

Similar Executives

Showing other executives

PRESIDENT Age

James CunniffElectromed
58
Kevin KennyOrthofix Medical
59
Paul BuckmanLivaNova PLC
68
Stephanie BoltonLivaNova PLC
42
ChunHsien TsaiAinos Inc
54
Franco PolettiLivaNova PLC
N/A
Tyler LipschultzOrthofix Medical
57
D LeeArtivion
56
Joseph HauserOrthopediatrics Corp
42
Jon SerbousekOrthofix Medical
63
Keyna SkeffingtonLivaNova PLC
61
Gregg SuttonSurModics
64
Daniel GerritzenOrthopediatrics Corp
54
Aviva McPherronOrthofix Medical
N/A
David BaileyOrthopediatrics Corp
45
Kimberley EltingOrthofix Medical
59
MBAMSHA CHEOrthopediatrics Corp
52
Gregory OdleOrthopediatrics Corp
54
Ryan MillerLivaNova PLC
N/A
Xtant Medical Holdings, Inc. develops, manufactures, and markets regenerative medicine products and medical devices for orthopedic and neurological surgeons in the United States and internationally. Xtant Medical Holdings, Inc. is headquartered in Belgrade, Montana. Xtant Medical operates under Medical Devices classification in the United States and is traded on AMEX Exchange. It employs 116 people. Xtant Medical Holdings (XTNT) is traded on NYSE MKT Exchange in USA. It is located in 664 Cruiser Lane, Belgrade, MT, United States, 59714 and employs 207 people. Xtant Medical is listed under Health Care Equipment & Supplies category by Fama And French industry classification.

Management Performance

Return On Equity-0.0877
Return On Asset-0.11

Xtant Medical Holdings Leadership Team

Elected by the shareholders, the Xtant Medical's board of directors comprises two types of representatives: Xtant Medical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Xtant. The board's role is to monitor Xtant Medical's management team and ensure that shareholders' interests are well served. Xtant Medical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Xtant Medical's outside directors are responsible for providing unbiased perspectives on the board's policies.
Sean Browne, CEO President
Scott Neils, Chief Officer
Kevin Brandt, Senior Vice President Chief Commercial Officer
Kevin ODare, VP US
Catherine Lundy, Vice Resources
Mark Schallenberger, Chief Officer

Xtant Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Xtant Medical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity-0.0877
Return On Asset-0.11
Profit Margin(0.03) %
Operating Margin(0.1) %
Current Valuation84.96 M
Shares Outstanding139.01 M
Shares Owned By Insiders7.83 %
Shares Owned By Institutions65.12 %
Number Of Shares Shorted197.47 K
Price To Earning(0.41) X

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Xtant Stock Analysis

When running Xtant Medical's price analysis, check to measure Xtant Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Xtant Medical is operating at the current time. Most of Xtant Medical's value examination focuses on studying past and present price action to predict the probability of Xtant Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Xtant Medical's price. Additionally, you may evaluate how the addition of Xtant Medical to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY